We didn't know then what we know now
10 years ago, there was NO CLUE that the anti-PS platform would constitute the SOLE upstream checkpoint for oncologic immunotherapy.
We know that now. BIG difference, my friend.
If Bavi were not the critical upstream immune checkpoint that it is, I wouldn't be in the stock.
But it is, so I am.
GLTAL!
Best,
JOE